July 15, 2024
You are here:  Home  >  Regions  >  Central Coast  >  Current Article

Amgen’s $28B merger bid gets tougher


California and five other states on June 22 joined the Federal Trade Commission's antitrust lawsuit to block Thousand Oaks-based biotech giant Amgen from buying another life sciences company, Horizon Therapeutics, for nearly $28 billion. Horizon, based in Illinois and Ireland, has a monopoly on Tepezza, a medicine that treats thyroid eye disease, and Krystexxa, a…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.